Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

ClinicalTrials.gov ID: NCT02403323

Public ClinicalTrials.gov record NCT02403323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 11:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension and Safety Monitoring Study of Patients With Moderately to Severely Active Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Protocol GA29144

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open-label extension and safety monitoring study is composed of two parts: Part 1 will evaluate the long-term safety and efficacy of continued etrolizumab treatment in participants with moderately to severely active Crohn's disease who were previously enrolled in the etrolizumab Phase III Study GA29144 (NCT02394028) and who meet eligibility criteria for enrollment into Part 1. In Part 2, participants who have stopped etrolizumab treatment (either by exiting Part 1 of this study or by entering directly from Study GA29144 \[NCT02394028\]) will be monitored for 92 weeks for progressive multifocal leukoencephalopathy (PML) and other safety events.

Study identification

NCT ID
NCT02403323
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
790 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 8, 2015 (Actual)
Primary completion
Oct 9, 2023 (Actual)
Completion
Oct 9, 2023 (Actual)
Last update posted
Dec 2, 2024

2015 – 2023

United States locations

U.S. sites
59
U.S. states
24
U.S. cities
54
Facility City State ZIP Site status
Valley Gastroenterology Consultants Arcadia California 91006 —
University of California San Diego Medical Center La Jolla California 92093-5354 —
VA Long Beach Healthcare System Long Beach California 90822 —
Digestive Care Associates, A Medical Corporation San Carlos California 94070 —
SDG Clinical Research San Diego California 92103 —
Uni. of California at San Francisco; Dept Pediatric, Div. of Gastroenterology, Hepatology & Nutri San Francisco California 94158 —
Peak Gastroenterology Associates Colorado Springs Colorado 80907 —
Innovative Medical Research of South Florida Aventura Florida 33180 —
West Central Gastroenterology d/b/a Gastro Florida Clearwater Florida 33756 —
University of Florida College of Medicine Gainesville Florida 32610 —
Borland-Groover Clinic Jacksonville Florida 32256 —
IMIC, Inc Miami Beach Florida 33140 —
FQL Research, LLC Miramar Florida 33025 —
Shafran Gastroenterology Center Winter Park Florida 32789 —
Emory University Hospital Atlanta Georgia 30322 —
Atlanta Gastroenterology Associates Atlanta Georgia 30342 —
Columbus Regional Research Institute Columbus Georgia 31904 —
Atlanta Center for Gastroenterology, PC Decatur Georgia 30033 —
Gastroenterology Associates of Central Georgia Macon Georgia 31201 —
Gastrointestinal Specialists of Georgia, PC Marietta Georgia 30060 —
Advanced Clinical Research Spokane Idaho 99202 —
Northwestern Uni-Feinberg School of Medicine Chicago Illinois 60611 —
University of Chicago Medical Center Chicago Illinois 60637 —
Southwest Gastroenterology Oak Lawn Illinois 60453 —
Carle Foundation Hospital Urbana Illinois 61801-2500 —
Cotton-O'Neil Clinical Research Center, Digestive Health Topeka Kansas 66606 —
Gastroenterology Associates, LLC Baton Rouge Louisiana 70809 —
Louisiana Research Center, LLC Shreveport Louisiana — —
University of Michigan Ann Arbor Michigan 48109 —
Gastroenterology Associates of Western Michigan, P.L.C. Grand Rapids Michigan 49506 —
Henry Ford Health System Novi Michigan 48377-3600 —
Center for Digestive Health Troy Michigan 48098 —
Mayo Clinic - Rochester Rochester Minnesota 55905 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Ehrhardt Clinical Research, LLC Belton Missouri 64012 —
Concorde Medical Group New York New York 10016 —
Weill Cornell Medical College-New York Presbyterian Hospital New York New York 10021 —
Lenox Hill Hospital New York New York 10075 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Charlotte Gastroenterology and Hepatology, P.L.L.C Charlotte North Carolina 28207 —
Vidant Medical Group, LLC DBA Vidant Multispeciality Clinic-Kinston Kinston North Carolina 28501 —
Consultants for Clinical Research Inc. Cincinnati Ohio 45219 —
Great Lakes Gastroenterology Research, LLC Mentor Ohio 44060 —
Digestive Disease Specialists, Inc. Oklahoma City Oklahoma 73112 —
Great Lakes Medical Research, LLC Harrisburg Pennsylvania 17110 —
Innovative Clinical Research Greenville South Carolina 29604 —
Gastro One Germantown Tennessee 38138 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
University of Texas Southwestern Medical Center; Internal Medicne Dallas Texas 75390-9151 —
Baylor College of Medicine Houston Texas 77030 —
Methodist Hospital Research Institute Houston Texas 77030 —
Wellness Clinical Research Center San Antonio Texas 78232 —
Texas Digestive Disease Consultants - Southlake Southlake Texas 76092 —
Digestive Health Specialists of Tyler Tyler Texas 75701 —
Ericksen Research and Development Clinton Utah 84015 —
University of Utah School of Medicine Salt Lake City Utah 84132 —
McGuire Research Institute; Gastroenterology Richmond Virginia 23249 —
Digestive Disease Institute; Virginia Mason Medical Center Seattle Washington 98101 —
University of Wisconsin Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 228 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02403323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2024 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02403323 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →